anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Callout

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 96,741
Current window 74,491-74,520
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all
18 30 60

Component

74,491-74,520 of 96,741

filter-aware
178
The slide highlights a potential discrepancy between official FDA reporting and actual event timing, suggesting either database lag or manufacturer reporting delays.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
179
The slide uses a 'back-of-the-envelope' calculation to argue that reported adverse events are undercounted.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
180
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
181
The slide presents a clinical case narrative alongside screenshots of FDA FAERS database records.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
183
The slide presents a clinical case study narrative, likely for pharmacovigilance or safety analysis.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
184
The slide highlights a potential cover-up or reporting discrepancy regarding a patient seizure.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
185
The slide presents a narrative summary of a medical case report, pointing out suspicious physician/company behavior regarding the reporting of heart palpitations.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
186
The slide presents a clinical case study from the FDA FAERS database, highlighting a potential drug-drug interaction or confounding factor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
187
This is a clinical case report document from the FDA Adverse Event Reporting System (FAERS).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
188
This is a raw FDA FAERS FOIA case report document.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
189
The slide presents a clinical case study analysis of a specific adverse event report (FAERS).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
190
This slide presents raw clinical case data from the FDA FAERS database to support a hypothesis about drug interactions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
191
The slide highlights a discrepancy between patient belief and sponsor assessment regarding drug causality.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
192
The slide highlights a specific safety concern regarding pitolisant (Wakix) and its interaction with CYP2D6 inhibitors.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
193
The slide uses a narrative structure to expose a potential cover-up or reporting failure regarding a serious adverse event.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
194
This is a medical case report summary, likely used for pharmacovigilance or safety analysis.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
195
This is a pharmacovigilance case report summary.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
196
The slide presents a specific pharmacovigilance case report, highlighting a positive dechallenge.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
197
This is a clinical case study/adverse event report sourced from FDA FAERS data.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
198
This appears to be a medical case report document from the FDA FAERS database.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
199
This is a clinical case study/adverse event report sourced from FDA FAERS data.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
200
This is a pharmacovigilance case report summary.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
201
The slide presents a patient-reported adverse event (FAERS) to challenge the safety profile of a pharmaceutical product.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
202
The slide explicitly frames the narrative as a potential cover-up, contrasting patient statements with official physician office clarifications.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
203
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
204
The slide highlights a discrepancy between the drug's safety profile as presented and the real-world experience of a physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
205
The slide presents a qualitative case study (anecdotal evidence) regarding a potential adverse drug event.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
206
The slide highlights specific clinical symptoms and diagnostic procedures (EKG, cardiac enzymes, telemetry) used to rule out cardiac issues.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
207
The slide uses a Q&A format to document a specific interaction between a doctor and a pharmaceutical sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
208
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit